Literature DB >> 11007960

Role of conformational alteration in the epidermal growth factor receptor (EGFR) function.

S Bishayee1.   

Abstract

This mini-review addresses the effect of glycosylation and phosphorylation on the conformational alterations of the epidermal growth factor receptor (EGFR). Based on studies with full-length and truncated EGFRs, we propose a model to suggest that receptor-receptor self-association, which occurs in the truncated receptor and depends on core glycosylation, is prevented in intact receptor by a certain extracellular domain and that the function of the ligand is to remove the negative constraint. We also propose, based on works with a conformation-specific antibody directed to an unphosphorylated peptide, that the interactions among negatively charged phosphotyrosine residues in the receptor molecule result in bringing two epitopes separated by a long stretch of amino acids close to each other to form an antibody-binding site. The implications of these posttranslational modifications on receptor functions are also discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007960     DOI: 10.1016/s0006-2952(00)00425-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Cell surface beta 1, 4-galactosyltransferase 1 promotes apoptosis by inhibiting epidermal growth factor receptor pathway.

Authors:  Zejuan Li; Hongliang Zong; Xiangfei Kong; Si Zhang; Hanzhou Wang; Qing Sun; Jianxin Gu
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

2.  Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.

Authors:  Qian Wu; Hai-Ou Liu; Yi-Dong Liu; Wei-Si Liu; Deng Pan; Wei-Juan Zhang; Liu Yang; Qiang Fu; Jie-Jie Xu; Jian-Xin Gu
Journal:  J Biol Chem       Date:  2014-11-24       Impact factor: 5.157

3.  An EGFR gene of the Pacific oyster Crassostrea gigas functions in wound healing and promotes cell proliferation.

Authors:  Lingling Sun; Pin Huan; Hongxia Wang; Fengsong Liu; Baozhong Liu
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

4.  PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.

Authors:  Hsin-Wei Liao; Jung-Mao Hsu; Weiya Xia; Hung-Ling Wang; Ying-Nai Wang; Wei-Chao Chang; Stefan T Arold; Chao-Kai Chou; Pei-Hsiang Tsou; Hirohito Yamaguchi; Yueh-Fu Fang; Hong-Jen Lee; Heng-Huan Lee; Shyh-Kuan Tai; Mhu-Hwa Yang; Maria P Morelli; Malabika Sen; John E Ladbury; Chung-Hsuan Chen; Jennifer R Grandis; Scott Kopetz; Mien-Chie Hung
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

5.  Proteasome inactivation promotes p38 mitogen-activated protein kinase-dependent phosphatidylinositol 3-kinase activation and increases interleukin-8 production in retinal pigment epithelial cells.

Authors:  Alexandre F Fernandes; Qingning Bian; Jian-Kang Jiang; Craig J Thomas; Allen Taylor; Paulo Pereira; Fu Shang
Journal:  Mol Biol Cell       Date:  2009-07-01       Impact factor: 4.138

6.  Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells.

Authors:  Angela J Mantha; Kathryn E McFee; Nima Niknejad; Glenwood Goss; Ian A Lorimer; Jim Dimitroulakos
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-26       Impact factor: 4.553

7.  EFFECT OF SELENIUM SUPPLEMENTATION ON PROTEOMIC SERUM BIOMARKERS IN ELDERLY MEN.

Authors:  A M Algotar; R Behnejad; P Singh; P A Thompson; C H Hsu; S P Stratton
Journal:  J Frailty Aging       Date:  2015

Review 8.  Targeting EGFR resistance networks in head and neck cancer.

Authors:  Vladimir Ratushny; Igor Astsaturov; Barbara A Burtness; Erica A Golemis; Joshua S Silverman
Journal:  Cell Signal       Date:  2009-03-01       Impact factor: 4.315

9.  Lewisy promotes migration of oral cancer cells by glycosylation of epidermal growth factor receptor.

Authors:  Wei-Ling Lin; Yi-Shiuan Lin; Guey-Yueh Shi; Chuan-Fa Chang; Hua-Lin Wu
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

10.  Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR.

Authors:  Fen Wang; Shuhang Wang; Zhijie Wang; Jianchun Duan; Tongtong An; Jun Zhao; Hua Bai; Jie Wang
Journal:  J Exp Clin Cancer Res       Date:  2012-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.